Clinical Trials Logo

Migraine With Typical Aura clinical trials

View clinical trials related to Migraine With Typical Aura.

Filter by:
  • None
  • Page 1

NCT ID: NCT03220113 Recruiting - Migraine Disorders Clinical Trials

Treatment of Chronic Migraine Headaches.

Migraine
Start date: July 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is assessment of the safety and efficacy of the De-Novo therapy in the treatment of craniofacial neuralgia and migraine headaches.This is an open-label study of simultaneous administration of combination of dexamethasone, lidocaine, and thiamine into the trigeminal nerve branches as well as greater and lesser occipital nerve bilaterally in one session. Patients who meet the exclusion and inclusion criteria are eligible for trial if they have experienced chronic migraine and craniofacial pain not responding to other prior therapies.

NCT ID: NCT00126035 Completed - Clinical trials for Migraine With Typical Aura

Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura

Start date: February 2004
Phase: N/A
Study type: Interventional

The purpose of the study was to assess the efficacy of Migraid in terms of preventing headaches in patients with migraine with typical aura. The secondary objectives were to assess whether Migraid is able to achieve pain relief and/or relief of migraine associated symptoms and to evaluate the safety and tolerability of the study treatment.